Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma
Xiao Li, Fei Qin, Li Yang, Liqian Mo, Lei Li, Lianbing Hou Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of China Abstract: Targeted nanoparticle (NP) delivery vehicles are emerging technologies, the full potential of which has yet t...
Guardado en:
Autores principales: | Li X, Qin F, Yang L, Mo LQ, Li L, Hou LB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa8d9d549e4e4be59f740e0f4322d859 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
por: Li X, et al.
Publicado: (2018) -
Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells
por: Xu W, et al.
Publicado: (2018) -
Conserved roles of C. elegans and human MANFs in sulfatide binding and cytoprotection
por: Meirong Bai, et al.
Publicado: (2018) -
Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang L, et al.
Publicado: (2015) -
MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell
por: Liu J, et al.
Publicado: (2016)